New Treatment for Chordoma

Scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal National Orthopedic Hospital NHS Trust suggest that patients with a rare bone cancer of the skull and spine called chordoma could be helped by existing drugs. This suggestion was made based on the discovery made by scientists that a group of chordoma patients have been found to have mutations in genes that are the target of existing drugs, known as PI3K inhibitors.

Related Links